Literature DB >> 20080844

Steroidogenic factor 1 overexpression and gene amplification are more frequent in adrenocortical tumors from children than from adults.

Madson Q Almeida1, Ibere Cauduro Soares, Tamaya C Ribeiro, Maria Candida B V Fragoso, Lidiane V Marins, Alda Wakamatsu, Rodrigo A Ressio, Mirian Y Nishi, Alexander A L Jorge, Antonio M Lerario, Venancio A F Alves, Berenice B Mendonca, Ana Claudia Latronico.   

Abstract

BACKGROUND: Steroidogenic factor 1 (SF-1) is a key determinant of endocrine development and function of adrenal cortex. SF-1 overexpression and gene amplification were previously demonstrated in a small group of pediatric adrenocortical tumors.
OBJECTIVE: Our objective was to determine the frequency of SF-1 protein expression and gene amplification in a large cohort of pediatric and adult adrenocortical tumors. PATIENTS: SF-1 protein expression was assessed in a cohort of 103 adrenocortical tumors from 36 children and 67 adults, whereas gene amplification was studied in 38 adrenocortical tumors (17 from children).
METHODS: Tissue microarray, multiplex ligation-dependent probe amplification, and quantitative real-time PCR were used.
RESULTS: A strong nuclear SF-1 expression was detected by tissue microarray in 56% (20 of 36) and 19% (13 of 67) of the pediatric and adult adrenocortical tumors, respectively (P = 0.0004). Increased SF-1 copy number was identified in 47% (eight of 17) and 10% (two of 21) of the pediatric and adult adrenocortical tumors, respectively (P = 0.02). All adrenocortical tumors with SF-1 gene amplification showed a strong SF-1 staining, whereas most of the tumors (61%) without SF-1 amplification displayed a weak or negative staining (P = 0.0008). Interestingly, a strong SF-1 staining was identified in five (29%) pediatric adrenocortical tumors without SF-1 amplification. The frequency of SF-1 overexpression and gene amplification was similar in adrenocortical adenomas and carcinomas.
CONCLUSION: We demonstrated a higher frequency of SF-1 overexpression and gene amplification in pediatric than in adult adrenocortical tumors, suggesting an important role of SF-1 in pediatric adrenocortical tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20080844     DOI: 10.1210/jc.2009-2040

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  25 in total

Review 1.  Adrenocortical stem and progenitor cells: implications for adrenocortical carcinoma.

Authors:  Derek P Simon; Gary D Hammer
Journal:  Mol Cell Endocrinol       Date:  2012-01-13       Impact factor: 4.102

2.  Progression to adrenocortical tumorigenesis in mice and humans through insulin-like growth factor 2 and β-catenin.

Authors:  Joanne H Heaton; Michelle A Wood; Alex C Kim; Lorena O Lima; Ferdous M Barlaskar; Madson Q Almeida; Maria C B V Fragoso; Rork Kuick; Antonio M Lerario; Derek P Simon; Ibere C Soares; Elisabeth Starnes; Dafydd G Thomas; Ana C Latronico; Thomas J Giordano; Gary D Hammer
Journal:  Am J Pathol       Date:  2012-07-15       Impact factor: 4.307

Review 3.  Regulation of the adrenocortical stem cell niche: implications for disease.

Authors:  Elisabeth M Walczak; Gary D Hammer
Journal:  Nat Rev Endocrinol       Date:  2014-10-07       Impact factor: 43.330

4.  Therapy of adrenocortical cancer: present and future.

Authors:  Daniela F Maluf; Brás H de Oliveira; Enzo Lalli
Journal:  Am J Cancer Res       Date:  2010-12-07       Impact factor: 6.166

Review 5.  Adrenocortical carcinoma: a clinician's update.

Authors:  Martin Fassnacht; Rossella Libé; Matthias Kroiss; Bruno Allolio
Journal:  Nat Rev Endocrinol       Date:  2011-03-08       Impact factor: 43.330

6.  POD-1 binding to the E-box sequence inhibits SF-1 and StAR expression in human adrenocortical tumor cells.

Authors:  Monica Malheiros França; Bruno Ferraz-de-Souza; Mariza Gerdulo Santos; Antonio Marcondes Lerario; Maria Candida Barisson Villares Fragoso; Ana Claudia Latronico; Rork D Kuick; Gary D Hammer; Claudimara F P Lotfi
Journal:  Mol Cell Endocrinol       Date:  2013-01-09       Impact factor: 4.102

Review 7.  Steroidogenic factor-1 and human disease.

Authors:  Ranna El-Khairi; John C Achermann
Journal:  Semin Reprod Med       Date:  2012-10-08       Impact factor: 1.303

8.  Expression of Wnt and TGF-β pathway components and key adrenal transcription factors in adrenocortical tumors: association to carcinoma aggressiveness.

Authors:  Helka Parviainen; Anja Schrade; Sanne Kiiveri; Renata Prunskaite-Hyyryläinen; Caj Haglund; Seppo Vainio; David B Wilson; Johanna Arola; Markku Heikinheimo
Journal:  Pathol Res Pract       Date:  2013-06-21       Impact factor: 3.250

9.  SEPT14 Is Associated with a Reduced Risk for Parkinson's Disease and Expressed in Human Brain.

Authors:  Liron Rozenkrantz; Ziv Gan-Or; Mali Gana-Weisz; Anat Mirelman; Nir Giladi; Anat Bar-Shira; Avi Orr-Urtreger
Journal:  J Mol Neurosci       Date:  2016-04-26       Impact factor: 3.444

Review 10.  Mouse models of adrenocortical tumors.

Authors:  Kaitlin J Basham; Holly A Hung; Antonio M Lerario; Gary D Hammer
Journal:  Mol Cell Endocrinol       Date:  2015-12-08       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.